Residual Pathological Stage at Radical Cystectomy Significantly Impacts Outcomes for Initial T2N0 Bladder Cancer

Journal of Urology

Volumn 182, Issue 2, 2009, Pages 459-465

  Isbarn, Hendrik ^a   Karakiewicz, Pierre I ^a   Shariat, Shahrokh F ^a   Capitanio, Umberto ^a   Palapattu, Ganesh S ^a   Sagalowsky, Arthur I ^a   Lotan, Yair ^a   Schoenberg, Mark P ^a   Amiel, Gilad E ^a   Lerner, Seth P ^a   Sonpavde, Guru ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

carcinoma, transitional cell; cystectomy, urinary bladder neoplasms, neoplasm staging

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; THERAPY EFFECT; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 67649972121     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.04.017     Document Type: Article

References (19)

1. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
2. Oosterlinck W., Lobel B., Jakse G., et al. Guidelines on bladder cancer. Eur Urol 41 (2002) 105
3. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51 (2007) 137
4. Volkmer B.G., Kuefer R., Bartsch Jr. G., et al. Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Cancer 104 (2005) 2384
5. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859
6. Nielsen M.E., Bastian P.J., Palapattu G.S., et al. Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection. Urology 70 (2007) 1091
7. Palapattu G.S., Shariat S.F., Karakiewicz P.I., et al. Cancer specific outcomes in patients with pT0 disease following radical cystectomy. J Urol 175 (2006) 1645
8. Thrasher J.B., Frazier H.A., Robertson J.E., et al. Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer?. J Urol 152 (1994) 393
9. Waehre H., Ous S., Klevmark B., et al. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer. Cancer 72 (1993) 3044
10. Dutta S.C., Smith Jr. J.A., Shappell S.B., et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166 (2001) 490
11. Shariat S.F., Karakiewicz P.I., Palapattu G.S., et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176 (2006) 2414
12. Bochner B.H., Kattan M.W., and Vora K.C. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 24 (2006) 3967
13. Sobin L.H., and Fleming I.D. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80 (1997) 1803
14. Lotan Y., Gupta A., Shariat S.F., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533
15. Shariat S.F., Khoddami S.M., Saboorian H., et al. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 171 (2004) 1122
16. Henson D.E., Hutter R.V., and Farrow G. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the cancer committee, College of American Pathologists. Task Force on the Examination of Specimens Removed From Patients With Prostate Cancer. Arch Pathol Lab Med 118 (1994) 779
17. Lee S.E., Jeong I.G., Ku J.H., et al. Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor. Urology 63 (2004) 873
18. Skinner E.C. The best treatment for high-grade T1 bladder cancer is cystectomy. Urol Oncol 25 (2007) 523
19. Karakiewicz P.I., Shariat S.F., Palapattu G.S., et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 176 (2006) 1354